OpenURL Connection Search

Select item for more details and to access through your institution.

RNA Exosome Component EXOSC4 Amplified in Multiple Cancer Types Is Required for the Cancer Cell Survival.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 1, p. 496, doi. 10.3390/ijms23010496
By:
- Taniue, Kenzui;
- Tanu, Tanzina;
- Shimoura, Yuki;
- Mitsutomi, Shuhei;
- Han, Han;
- Kakisaka, Rika;
- Ono, Yusuke;
- Tamamura, Nobue;
- Takahashi, Kenji;
- Wada, Youichiro;
- Mizukami, Yusuke;
- Akimitsu, Nobuyoshi
Publication type:
Article
Clinicopathological characteristics of Epstein–Barr virus and microsatellite instability subtypes of early gastric neoplasms classified by the Japanese and the World Health Organization criteria.
Published in:
Journal of Pathology: Clinical Research, 2021, v. 7, n. 4, p. 397, doi. 10.1002/cjp2.209
By:
- Tanabe, Hiroki;
- Mizukami, Yusuke;
- Takei, Hidehiro;
- Tamamura, Nobue;
- Omura, Yuhi;
- Kobayashi, Yu;
- Murakami, Yuki;
- Kunogi, Takehito;
- Sasaki, Takahiro;
- Takahashi, Keitaro;
- Ando, Katsuyoshi;
- Ueno, Nobuhiro;
- Kashima, Shin;
- Yuzawa, Sayaka;
- Hasegawa, Kimiharu;
- Sumi, Yasuo;
- Tanino, Mishie;
- Fujiya, Mikihiro;
- Okumura, Toshikatsu
Publication type:
Article
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway.
Published in:
2022
By:
- Kawabata, Hidemasa;
- Ono, Yusuke;
- Tamamura, Nobue;
- Oyama, Kyohei;
- Ueda, Jun;
- Sato, Hiroki;
- Takahashi, Kenji;
- Taniue, Kenzui;
- Okada, Tetsuhiro;
- Fujibayashi, Syugo;
- Hayashi, Akihiro;
- Goto, Takuma;
- Enomoto, Katsuro;
- Konishi, Hiroaki;
- Fujiya, Mikihiro;
- Miyakawa, Keita;
- Tanino, Mishie;
- Nishikawa, Yuji;
- Koga, Daisuke;
- Watanabe, Tsuyoshi
Publication type:
journal article

Found: 3

RNA Exosome Component EXOSC4 Amplified in Multiple Cancer Types Is Required for the Cancer Cell Survival.

Clinicopathological characteristics of Epstein–Barr virus and microsatellite instability subtypes of early gastric neoplasms classified by the Japanese and the World Health Organization criteria.

Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway.